You have 9 free searches left this month | for more free features.

Pulmonary Vascular Resistance

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PV Loop and Pulmonary Hypertension

Recruiting
  • Pulmonary Vascular Resistance Abnormality
  • Measuring VA Coupling
  • San Francisco, California
  • +1 more
Jul 29, 2022

PIMR and Pulmonary Vascular Disease

Recruiting
  • Pulmonary Hypertension
  • Pulmonary Index of Microcirculatory Resistance
  • +2 more
  • Los Angeles, California
    Ronald Reagan UCLA Medical Center
Apr 24, 2023

The Role of the Pulmonary Vasculature in the Fontan Circulation

Recruiting
  • Congenital Heart Disease
  • +3 more
    • Groningen, Netherlands
      University Medical Center Groningen
    Oct 19, 2021

    Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 3

    Recruiting
    • Hypertension, Pulmonary
    • +2 more
    • levosimendan at a dose of 3 mcg/kg
    • +2 more
    • Athens, Greece
      Onassis Cardiac Surgery Center
    Feb 8, 2022

    Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 6

    Recruiting
    • Hypertension, Pulmonary
    • +2 more
    • levosimendan at a dose of 6 mcg/kg
    • milrinone at a dose of 50 mcg/kg
    • Athens, Greece
      Onassis Cardiac Surgery Center
    Feb 8, 2022

    ET1 Concentration, Metabolic Pathway Activation, and Pulmonary

    Recruiting
    • Single-ventricle
    • +4 more
    • Research Blood Sampling
    • Denver, Colorado
      Children's Hospital Colorado
    Aug 16, 2021

    Mitochondrial Substrate Utilization in the Diabetic Human Heart

    Recruiting
    • Heart Failure
    • +4 more
      • Düsseldorf, Germany
        University-Hospital Düsseldorf Division of Cardiology, Pulmonary
      Jul 14, 2023

      Chronic Thromboembolic Pulmonary Hypertension, CTEPH Trial in Worldwide (Riociguat, Placebo, Pulmonary endarterectomy)

      Terminated
      • Chronic Thromboembolic Pulmonary Hypertension
      • CTEPH
      • La Jolla, California
      • +3 more
      May 31, 2021

      Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis Trial in Dresden, Heidelberg (Riociguat Oral

      Recruiting
      • Pulmonary Vascular Disorder
      • +3 more
      • Riociguat Oral Tablet
      • Placebo
      • Dresden, Germany
      • +1 more
      Jan 26, 2023

      Pulmonary Arterial Hypertension, Right Heart Failure, Right Ventricular Dysfunction Trial in Seattle (Valsartan 40 mg, Placebo)

      Not yet recruiting
      • Pulmonary Arterial Hypertension
      • +3 more
      • Valsartan 40 mg
      • Placebo
      • Seattle, Washington
        University of Washington Medical Center
      Sep 13, 2023

      Collapsed Lung, Hemodynamic Stability Trial (Alveolar recruitment maneuver, Nitric Oxide)

      Not yet recruiting
      • Collapsed Lung
      • Hemodynamic Stability
      • Alveolar recruitment maneuver
      • Nitric Oxide
      • (no location specified)
      Oct 20, 2023

      Patients With Kidney Transplantation

      Recruiting
      • Pulmonary Hypertension
      • +2 more
      • exercise echocardiography
      • Graz, Austria
        Medical University of Graz, Department of Internal Medicine, Div
      Nov 15, 2022

      Pulmonary Artery Hypertension Trial (XBD173)

      Not yet recruiting
      • Pulmonary Artery Hypertension
      • (no location specified)
      Sep 6, 2023

      Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

      Active, not recruiting
      • Pulmonary Vascular Disease
      • +2 more
      • Relocation from HA to LA
      • Zurich, Switzerland
        Respiratory Clinic, University Hospital of Zurich
      Oct 17, 2023

      COPD Trial in Miami (Bevespi, Bretzri)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Miami, Florida
        University of Miami
      Jan 23, 2023

      Pulmonary Vascular Disorder, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

      Active, not recruiting
      • Pulmonary Vascular Disorder
      • +2 more
      • Supplemental oxygen therapy
      • Sham Oxygen therapy
      • Zurich, Switzerland
        University Hospital Zürich
      Oct 9, 2023

      Chronic Thromboembolic Pulmonary Hypertension Trial in Beijing (Balloon pulmonary angioplasty)

      Recruiting
      • Chronic Thromboembolic Pulmonary Hypertension
      • Balloon pulmonary angioplasty
      • Beijing, China
      • +1 more
      Dec 27, 2022

      Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

      Active, not recruiting
      • Pulmonary Vascular Disease
      • +2 more
      • Assessment without intervention at High altitude
      • Relocation to sea level for 2 days
      • Zurich, Switzerland
        University Hospital Zurich
      Oct 2, 2023

      Novel Index (PIMR) in PAH

      Recruiting
      • Pulmonary Hypertension
      • Pulmonary Index of Microcirculatory Resistance
      • Right Ventricle Index of Microcirculatory Resistance
      • Los Angeles, California
        Ronald Reagan UCLA Medical Center
      Apr 17, 2023

      Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

      Recruiting
      • Pulmonary Vascular Disease
      • +2 more
      • Relocation to sea level
      • Zurich, Switzerland
        University Hospital Zurich
      Aug 9, 2023

      Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich

      Recruiting
      • Pulmonary Vascular Disease
      • +2 more
      • 6-minute walk distance (6MWD) test
      • 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
      • Zürich, Switzerland
        University Hospital Zürich
      Aug 18, 2023

      Heart Failure Trial in Poland (Sacubitril-valsartan, Enalapril, )

      Not yet recruiting
      • Heart Failure
      • Białystok, Poland
      • +4 more
      Aug 2, 2022

      Pulmonary Arterial Hypertension, Insulin Resistance Trial in Cleveland (Nutrition and Exercise)

      Active, not recruiting
      • Pulmonary Arterial Hypertension
      • Insulin Resistance
      • Nutrition and Exercise
      • Cleveland, Ohio
        Cleveland Clinic Foundation
      May 6, 2022

      Peripheral Arterial Disease Trial (Peripheral vascular flow reserve measurement)

      Not yet recruiting
      • Peripheral Arterial Disease
      • Peripheral vascular flow reserve measurement
      • (no location specified)
      Aug 21, 2023

      Pulmonary Vascular Dysfunction asCause of Persistent Exertional

      Recruiting
      • COVID-19
      • pulmonary vascular dysfunction
      • pulmonary vascular function
      • Giessen, Germany
        Natascha Sommer
      May 13, 2022